// App-Quantinova.ai

TCT-212 : Twenty-Four Month Results in Patients With Resistant Hypertension After Endovascular Ultrasound Renal Denervation in the RADIANCE-HTN TRIO Trial

Researchers

Presenter

  • Michael Bloch

Principal Investigators

  • Ajay Kirtane

  • Felix Mahfoud

  • Michel Azizi

  • Jan Basile

  • Joost Daemen

  • Manish Saxena

  • Philippe Gosse

  • Kintur Sanghvi

  • Roland Schmieder

Medical Centers

  • Université Paris‐Créteil, Paris, France

  • Medical University of South Carolina, Ralph H. Johnson VA Medical Center, Charleston, South Carolina, USA

  • Barts Health NHS Trust, London, United Kingdom

  • Erasmus Medical Center, Rotterdam, THE NETHERLANDS

  • Renown Institute for Heart and Vascular Health, Reno, Nevada, USA

  • Deborah Heart & Lung Center, Princeton, New Jersey, USA

  • AP-HP, Hôpital Européen Georges-Pompidou, Hypertension Department, Paris, France

  • University Hospital Erlangen, Erlangen, GERMANY

  • NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York, USA

  • Universitaire (CHU) de Bordeaux, Bordeaux, France

  • Saarland University Medical Center, Homburg/Saar, Germany

Locations

  • France

  • United States

  • United Kingdom

  • Netherlands

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Hypertension

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved